Komplikasi Sistem Saraf Pusat pada COVID-19
DOI:
https://doi.org/10.55175/cdk.v48i11.144Keywords:
sistem saraf pusat, COVID-19, komplikasiAbstract
Coronavirus disease-19 disebabkan oleh virus SARS-CoV-2 yang menyebabkan pandemi sejak Maret 2020. COVID-19 tidak hanya menyebabkan komplikasi pernapasan dan kardiovaskular, tetapi dapat menyebabkan komplikasi sistem saraf pusat yang juga berkontribusi terhadap mortalitas dan morbiditas. Beberapa komplikasi sistem saraf pusat pada COVID-19 adalah stroke iskemik, stroke hemoragik, meningoensefalitis, acute transverse myelitis, dan ensefalopati. Stroke iskemik pada COVID-19 disebabkan oleh beberapa mekanisme, di antaranya koagulopati, disfungsi endotel, kardioemboli, invasi virus ke sistem saraf pusat, dan terapi imunoglobulin. Stroke hemoragik dapat disebabkan oleh kerusakan endotel akibat inflamasi menyebabkan disregulasi tekanan darah yang meningkatkan risiko stroke hemoragik. Meningoensefalitis pada COVID-19 disebabkan invasi virus langsung melalui cribriform plate atau karena kerusakan endotel yang menjadi pintu masuk SARS-CoV-2 ke otak. Mielitis transversa pada COVID-19 disebabkan hiperinflamasi sistemik, molecular mimicry, dan epitope spreading. Kegagalan organ multipel pada pasien COVID-19 akibat badai sitokin dapat menyebabkan ensefalopati.
Coronavirus disease-19 is caused by the SARS-CoV-2 virus that has been causing a pandemic since March 2020. Besides respiratory and cardiovascular complications, COVID-19 can cause complications to central nervous system that also contribute to mortality and morbidity. Some central nervous system complications in COVID-19 are ischemic stroke, hemorrhagic stroke, meningoencephalitis, acute transverse myelitis, and encephalopathy. Ischemic stroke in COVID-19 is caused by several mechanisms, including coagulopathy, endothelial dysfunction, cardioembolism, viral invasion of the central nervous system and immunoglobulin therapy. Hemorrhagic stroke can be associated with blood pressure dysregulation caused by inflammational endothelial damage. Meningoencephalitis in COVID-19 can be caused by direct viral invasion through the cribriform plate or due to endothelial damage that facilitate SARS-CoV-2 entrance to the brain. Transverse myelitis in COVID-19 is caused by systemic hyperinflammation, molecular mimicry and epitope spreading. Multiple organ failure in COVID-19 patients due to a cytokine storm can lead to encephalopathy.
Downloads
References
Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Bio-Medica Atenei Parm. 2020;91(1):157–60.
Indonesia COVID: 2,780,803 Cases and 71,397 Deaths - Worldometer [Internet]. [cited 2021 Jul 16]. Available from: https://www.worldometers.info/coronavirus/country/indonesia/
COVID live update: 190,020,508 cases and 4,086,904 deaths from the coronavirus - Worldometer [Internet]. [cited 2021 Jul 16]. Available from: https://www.worldometers.info/coronavirus/
Ozma MA, Maroufi P, Khodadadi E, Köse Ş, Esposito I, Ganbarov K, et al. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Infez Med. 2020;28(2):153–65.
Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.
Desforges M, Le Coupanec A, Dubeau P, Bourgouin A, Lajoie L, Dubé M, et al. Human coronaviruses and other respiratory viruses: Underestimated opportunistic pathogens of the central nervous system? Viruses. 2020;12(1):14.
Pleasure SJ, Green AJ, Josephson SA. The spectrum of neurologic disease in the severe acute respiratory syndrome coronavirus 2 pandemic infection: Neurologists move to the frontlines. JAMA Neurol. 2020;77(6):679–80.
Chou SHY, Beghi E, Helbok R, Moro E, Sampson J, Altamirano V, et al. Global incidence of neurological manifestations among patients hospitalized with COVID-19—A report for the GCS-NeuroCOVID consortium and the ENERGY consortium. JAMA Netw Open. 2021;4(5):e2112131.
Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–90.
Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): Encephalopathy [Internet]. [cited 2021 Jul 16]. Available from: https://www.cureus.com/articles/29414-neurological-complications-of-coronavirus-disease-covid-19-encephalopathy
Moriguchi T, Harii N, Goto J, Harada D, Sugawara H, Takamino J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2020;94:55–8.
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19-associated acute hemorrhagic necrotizing encephalopathy: Imaging features. Radiology 2020;296(2):119–20.
Dhama K, Khan S, Tiwari R, Sircar S, Bhat S, Malik YS, et al. Coronavirus disease 2019–COVID-19. Clin Microbiol Rev. 33(4):e00028-20.
Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13(5):667–73.
Yuki K, Fujiogi M, Koutsogiannaki S. COVID-19 pathophysiology: A review. Clin Immunol Orlando Fla. 2020;215:108427.
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study - ScienceDirect [Internet]. [cited 2021 Jul 17]. Available from: https://www.sciencedirect.com/science/article/pii/S0140673620302117
Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State - PubMed [Internet]. [cited 2021 Jul 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/32191259/
Yokoo P, Fonseca E, Neto R, Ishikawa W, Silva M, Yanata E. COVID-19 myocarditis: A case report COVID-19 myocarditis: A case report [Internet]. [cited 2021 Aug 8]. Available from: https://www.scielo.br/j/eins/a/hsVGMRZRxLVjh9dYnbvpLJR/?lang=en
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 Novel Coronavirus-Infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9.
Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID-19 - PubMed [Internet]. [cited 2021 Jul 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/32247631/
Fox S, Akmatbekov A, Harbert J, Guang L, Brown JQ, Heide RS. Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans - PubMed [Internet]. [cited 2021 Jul 17]. Available from: https://pubmed.ncbi.nlm.nih.gov/32473124/
Kordzadeh-Kermani E, Khalili H, Karimzadeh I. Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiol.:10.2217/fmb-2020–0110.
Bridwell R, Long B, Gottlieb M. Neurologic complications of COVID-19. Am J Emerg Med. 2020;38(7):1549.e3-1549.e7.
Chow CCN, Magnussen J, Ip J, Su Y. Acute transverse myelitis in COVID-19 infection. BMJ Case Rep CP. 2020;13(8):236720.
Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): Encephalopathy. Cureus 2020;12(3):7352.
Eskandar EN, Altschul DJ, Ramos R, Cezayirli P, Unda S, Benton J, et al. Neurologic syndromes predict higher in-hospital mortality in COVID-19 | Neurology [Internet]. [cited 2021 Jul 30]. Available from: https://n.neurology.org/content/96/11/e1527
Sellner J, Taba P, Öztürk S, Helbok R. The need for neurologists in the care of COVID-19 patients. Eur J Neurol. 2020;27(9):31–2.
Madani Neishaboori A, Moshrefiaraghi D, Mohamed Ali K, Toloui A, Yousefifard M, Hosseini M. Central nervous system complications in COVID-19 patients; A systematic review and meta-analysis based on current evidence. Arch Acad Emerg Med. 2020;8(1):62.
Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G. Neurological involvement of coronavirus disease 2019: A systematic review. J Neurol. 2020;1–19.
Spence JD, Freitas GR de, Pettigrew LC, Ay H, Liebeskind DS, Kase CS, et al. Mechanisms of stroke in COVID-19. Cerebrovasc Dis. 2020;49(4):451–8.
Cummings MJ, Baldwin MR, Abrams D, Jacobson SD, Meyer BJ, Balough EM, et al. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: A prospective cohort study. Lancet Lond Engl. 2020;395(10239):1763–70.
Modin D, Claggett B, Pedersen CS, Lassen MC Skaarup KG, Jensen JU, et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction [Internet]. [cited 2021 Jul 24]. Available from: https://www.ahajournals.org/doi/epub/10.1161/CIRCULATIONAHA.120.050809
Ojo AS, Balogun SA, Idowu AO. Acute ischemic stroke in COVID-19: Putative mechanisms, clinical characteristics, and management. Neurol Res Int. 2020;2020:e7397480.
Tzilas V, Manali E, Papiris S, Bouros D. Intravenous immunoglobulin for the treatment of COVID-19: A promising tool. Respiration. 2020;99(12):1087–9.
Caress JB, Cartwright MS, Donofrio PD, Peacock JE. The clinical features of 16 cases of stroke associated with administration of IVIg. Neurology 2003;60(11):1822–4.
Hauser SL, Joseph SA. Harrison’s neurology in clinical medicine. 4th ed. McGraw Hill. 2016.
Krishnamurthi RV, Moran AE, Forouzanfar MH, Bennett DA, Mensah GA, Lawes CMM, et al. The global burden of hemorrhagic stroke: A summary of findings from the GBD 2010 study. Glob Heart. 2014;9(1):101–6.
Van Asch CJ, Luitse MJ, Rinkel GJ, van der Tweel I, Algra A, Klijn CJ. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: A systematic review and meta-analysis. Lancet Neurol. 2010;9(2):167–76.
Mayza A, Safri AY, Rasyid A, Tiksnadi A, Budikayanti A, Imran D, et al. Buku ajar neurologi. Departemen Neurologi Fakultas Kedokteran Universitas Indonesia; 2017.
Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, et al. COVID-19 associated ischemic stroke and hemorrhagic stroke: Incidence, potential pathological mechanism, and management. Front Neurol. 2020;11:571996.
Razavi AS, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: Causative or coincidental? - PubMed [Internet]. [cited 2021 Jul 19]. Available from: https://pubmed.ncbi.nlm.nih.gov/32322398/
Frediansyah A, Syahrul S, Maliga HA, Ilmawan M, Fahriani M, Mamada SS, et al. Hemorrhagic and ischemic stroke in patients with coronavirus disease 2019: Incidence, risk factors, and pathogenesis-a systematic review and meta-analysis [Internet]. [cited 2021 Jul 24]. Available from: http://lipi.go.id/publikasi/Hemorrhagic-andischemic-stroke-in-patients-with-coronavirus-disease-2019-incidence-risk-factors-and-pathogenesis-a-systematic-review-and-meta-analysis/39951
Cantu RM, M Das J. Viral Meningitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 [cited 2021 Jul 20]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK545217/
Steiner I, Budka H, Chaudhuri A, Koskiniemi M, Sainio K, Salonen O, et al. Viral meningoencephalitis: A review of diagnostic methods and guidelines for management. Eur J Neurol. 2010;17(8):999-57.
Mondal R, Ganguly U, Deb S, Shome G, Pramanik S, Bandyopadhyay D, et al. Meningoencephalitis associated with COVID-19: A systematic review. J Neurovirol. 2020;1–14.
Abenza Abildúa MJ, Atienza S, Carvalho Monteiro G, Erro Aguirre ME, Imaz Aguayo L, Freire Álvarez E, et al. Encephalopathy and encephalitis during acute SARSCoV-2 infection. Spanish Society of Neurology’s COVID-19 Registry. Neurologia 2021;36(2):127–34.
Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL, et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. Lancet Psychiatry. 2020;7(10):875–82.
Lu P, Peng F, Zhang Y, Zhang L, Li N, Sun L, et al. COVID‑19‑associated meningoencephalitis: A case report and literature review. Exp Ther Med. 2021;21(4):1–1.
Baig AM, Khaleeq A, Ali U, Syeda H. Evidence of the COVID-19 virus targeting the CNS: Tissue distribution, host–virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci. 2020;11(7):995–8.
Román GC, Gracia F, Torres A, Palacios A, Gracia K, Harris D. Acute transverse myelitis (ATM): Clinical review of 43 patients with COVID-19-associated ATM and 3 postvaccination ATM serious adverse events with the ChAdOx1 nCoV-19 vaccine (AZD1222). Front Immunol [Internet]. 2021 [cited 2021 Jul 20];0. Available from: https://www.frontiersin.org/articles/10.3389/fimmu.2021.653786/full
Schulte. Systematic review of cases of acute myelitis in individuals with COVID‐19. Eur J Neurol - Wiley Online Library [Internet]. [cited 2021 Jul 25]. Available from:https://onlinelibrary.wiley.com/doi/10.1111/ene.14952
Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ.2020;368:1091.
Yin R, Yang Z, Wei Y, Li Y, Chen H, Liu Z, et al. Clinical characteristics of 106 patients with neurological diseases and co-morbid coronavirus disease 2019: A retrospective study. medRxiv. 2020;2020.04.29.20085415.
Shah VA, Nalleballe K, Zaghlouleh ME, Onteddu S. Acute encephalopathy is associated with worse outcomes in COVID-19 patients. Brain Behav Immun - Health.2020;8:100136.
Anand P, Zhou L, Bhadelia N, Hamer DH, Greer DM, Cervantes-Arslanian AM. Neurologic findings among inpatients with COVID-19 at a safety-net US Hospital. Neurol Clin Pract. 2021;11(2):83–91.
Garg RK, Paliwal VK, Gupta A. Encephalopathy in patients with COVID-19: A review. J Med Virol. 2021;93(1):206–22.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cermin Dunia Kedokteran
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
